SF 1856 Minnesota Senate · 2025-2026 Regular Session

Usage of artificial intelligence in the utilization review process prohibition provision

SF 1856 prohibits health insurance utilization review organizations in Minnesota from using artificial intelligence in any part of their review, evaluation, determination, or appeals processes. The bill directly affects health insurers and their utilization review contractors by banning AI tools in decisions about patient care coverage. It amends Minnesota Statutes 2024, section 62M.02, defining "artificial intelligence" per federal law (15 U.S.C. §9401) and explicitly banning its use in these processes. The law creates a clear policy change requiring human review for insurance coverage decisions.

Issues: ✓ Healthcare ✗ Technology

Bill status died 1 of 4 stages cleared

Introduction

Feb 2025

Committee Review

Floor Vote

Governor

Introduced Feb 24, 2025 Last action Mar 18, 2026

Maddy AI version diff · 1 comparison

What changed between versions

Introduction → 1st Engrossment · 3 edits · Mar 18, 2026

MINOR

The bill was updated from its introduction to its first engrossment version, adding new sections that explicitly authorize the Attorney General to enforce the prohibition on using artificial intelligence in medical utilization reviews. It also amended existing statutes to require that physicians or licensed pharmacists personally review adverse clinical determinations and must attest in writing that AI was not used in the process.

Scope change

The bill's scope expanded to include explicit enforcement authority for the Attorney General and strengthened requirements for human oversight in medical review decisions.

ENFORCEMENT

Added authority for the Attorney General to enforce the prohibition on using artificial intelligence in utilization review processes.

REQUIREMENT

Added a mandatory written attestation requirement for physicians or pharmacists to confirm that artificial intelligence was not used when making adverse clinical determinations.

Amended the statute to clarify that a licensed physician or pharmacist must personally conduct reviews for adverse determinations, with specific requirements for their license and medical specialty.

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 18, 2026

Committee

Comm report: Amended, No recommendation, re-referred to Commerce and Consumer Protection

upper

Feb 26, 2026

Committee

Withdrawn and re-referred to Judiciary and Public Safety

upper

Feb 24, 2025

Committee

Referred to Commerce and Consumer Protection

upper

Feb 24, 2025

Introduced

Introduction and first reading

upper

1 primary · 3 co-sponsors